Syndax grants inducement stock options for 213,300 shares to nine new employees

By Public Technologies
  • Syndax Pharmaceuticals granted inducement stock options covering 213,300 common shares to nine new employees on Oct. 1, 2026.
  • Awards were issued under the company’s 2023 Inducement Plan.
  • Options vest over four years, with 25% vesting after one year.
  • Remaining shares vest monthly at 1/48 over the next 36 months, subject to continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610021601PRIMZONEFULLFEED9838045) on October 02, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk